![Laxminarayan Bhat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 78 130 $ in data 30/06/2026
Dr. Laxminarayan Bhat is a President, Chief Executive Officer & Director at Reviva Pharmaceuticals Holdings, Inc. and a President, Chief Executive Officer & Director at Reviva Pharmaceuticals, Inc. He is on the Board of Directors at Reviva Pharmaceuticals Holdings, Inc. and Reviva Pharmaceuticals, Inc. Dr. Bhat was previously employed as a Research Scientist by ARYx Therapeutics, Inc. and a Research Scientist by XenoPort, Inc. He received his doctorate degree from North-Eastern Hill University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 25/03/2026 | 124.213 ( 0,97% ) | 78 130 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Fondatore | 11/12/2020 |
Reviva Pharmaceuticals, Inc.
 Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company developing therapies for unmet medical needs in central nervous system, cardiovascular, metabolic and inflammatory diseases | Fondatore | 01/01/2006 |
| Società | Posizione | Fine |
|---|---|---|
| ARYX THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 02/01/2006 |
| XENOPORT, INC. | Direttore Tecnico/Scientifico/R&S | 02/01/2004 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Reviva Pharmaceuticals, Inc.
Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company developing therapies for unmet medical needs in central nervous system, cardiovascular, metabolic and inflammatory diseases | Health Technology |
ARYx Therapeutics, Inc.
 ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
North-Eastern Hill University
 North-Eastern Hill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reviva Pharmaceuticals Holdings, Inc.
 Reviva Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for central nervous system, cardio vascular, metabolic and inflammatory diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
